BACK TO TOP
KSE100
179,603.73
-908.91
(-0.50%)
KSE100PR
56,356.03
-292.69
(-0.52%)
ALLSHR
108,021.18
-379.49
(-0.35%)
KSE30
54,828.32
-379.24
(-0.69%)
KMI30
253,396.08
-1976.44
(-0.77%)
BKTI
51,913.39
-259.93
(-0.50%)
OGTI
35,053.02
-295.86
(-0.84%)
KMIALLSHR
69,330.18
-398.02
(-0.57%)
PSXDIV20
81,446.36
-570.79
(-0.70%)
UPP9
62,719.87
-560.43
(-0.89%)
NITPGI
46,619.29
-387.95
(-0.83%)
NBPPGI
50,623.34
-339.04
(-0.67%)
MZNPI
31,476.62
-241.99
(-0.76%)
JSMFI
46,945.60
476.36
(1.03%)
ACI
25,064.12
-70.98
(-0.28%)
JSGBKTI
74,148.24
-563.59
(-0.75%)
HBLTTI
18,006.66
12-02-2026
-0.38
(0.00%)
MII30
23,068.59
-183.78
(-0.79%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.91.40
0.34
(0.37%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Feb 13, 2026 4:47 PM
REG
DFC
CSF
ODL
Open
91.25
High
92.34
Low
89.25
Volume
4,587,408
CIRCUIT BREAKER
81.95 — 100.17
DAY RANGE
89.25 — 92.34
52-WEEK RANGE ^
60.50 — 105.98
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
91.06
VAR
13.00
HAIRCUT
17.50
P/E Ratio (TTM) **
23.38
1-Year Change * ^
-13.32%
YTD Change * ^
8.04%
Last update: Fri, Feb 13, 2026 4:39 PM
Open
90.59
High
93.00
Low
89.70
Close
91.80
Change
0.20%
LDCP
91.62
Volume
1,053,500
Total Trades
577
CIRCUIT BREAKER
82.46 — 100.78
DAY RANGE
89.70 — 93.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Feb 1, 2026 3:49 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
93.67
Volume
0
Total Trades
0
CIRCUIT BREAKER
84.30 — 103.04
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:07 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
91.61
Volume
0
Total Trades
0
CIRCUIT BREAKER
82.45 — 100.77
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Dec 28, 2025 3:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
92.64
Volume
0
Total Trades
0
CIRCUIT BREAKER
83.38 — 101.90
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
20,881,353.68
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
Oct 29, 2025Financial Results for the Quarter Ended View   PDF
Oct 7, 2025Transmission of Annual Report for the Year Ended View   PDF
Oct 2, 2025Financial Results for the year ended View   PDF
DateTitleDocument
Feb 3, 2026Board meeting View   
Feb 3, 2026Board Meeting
REVOKED
View   
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
Oct 24, 2025Board Meeting View   
DateTitleDocument
Feb 11, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Feb 4, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 30, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 30, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 30, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q1 2026Q3 2025Q2 2025Q1 2025
Sales3,370,2473,341,1083,534,4323,224,645
Profit after Taxation203,691220,375256,979201,497
EPS0.890.961.120.88
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports